Balanced news tone
News Sentiment
RDHL sentiment intelligence
Redhill Biopharma Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
57
Balanced news tone
42 relevant articles
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-21.4% over one week, -21.4% over four weeks, trend inactive, and below fair value.
Redhill Biopharma Ltd (RDHL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
82/100 classification
One-week reaction
-21.4%
Price reacting lower
Trend fit
Trend inactive
-21.4% over four weeks
Fair value
-90.9%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
16
Neutral
23
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Stock Titan
Direct company coverage
[EFFECT] RedHill Biopharma Ltd. SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Stock Titan
PR Newswire
Direct company coverage
RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- PR Newswire
PR Newswire
Direct company coverage
RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- PR Newswire
PR Newswire
Direct company coverage
Joint U.S. Commercialization of RedHill's Talicia® Commences
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Feb 2026 08:00
- Source
- PR Newswire
Investing.com
Direct company coverage
Redhill Biopharma stock soars on GLP-1 side effect treatment progress
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jan 2026 08:00
- Source
- Investing.com
PR Newswire
Direct company coverage
RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Dec 2025 08:00
- Source
- PR Newswire
PharmTech.com
Direct company coverage
RedHill's $1.8M Middle East Deal Signals Global Demand for Effective H. pylori Treatment
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Oct 2025 07:00
- Source
- PharmTech.com
PR Newswire
Direct company coverage
RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 Sep 2025 07:00
- Source
- PR Newswire
PR Newswire
Direct company coverage
RedHill Biopharma Secures U.S. Government Funding through BARDA to Advance Opaganib for Ebola Treatment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Oct 2024 07:00
- Source
- PR Newswire
Stock Titan
Direct company coverage
RedHill's Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Sep 2024 07:00
- Source
- Stock Titan
MarketBeat
Direct company coverage
Top Redhill Biopharma (RDHL) Competitors 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2020 03:00
- Source
- MarketBeat
TradingView
Direct company coverage
RDHL Stock Price and Chart — NASDAQ:RDHL
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jul 2017 03:06
- Source
- TradingView